Charak Pharma Takzema Tablet – 30 Tablets
₹90.00 ₹100.00
Out of stock
- Manufactured by: charak pharma private limited
- As per physician’s advice may help in treatment of eczema
- Dosage: one tablet twice day
Ask a question
Your question will be answered by a store representative or other customers.
Thank you for the question!
Your question has been received and will be answered soon. Please do not submit the same question again.
Error
An error occurred when saving your question. Please report it to the website administrator. Additional information:
Add an answer
Thank you for the answer!
Your answer has been received and will be published soon. Please do not submit the same answer again.
Error
An error occurred when saving your answer. Please report it to the website administrator. Additional information:
Description
| Brand | Charak |
| Item Form | Tablet |
| Product Benefits | Itch Control |
| Active Ingredients | Calcium |
| Age Range (Description) | Adult |
| Use for | Skin |
| Specific Uses For Product | Eczema |
| Number of Items | 3 |
| Net Quantity | 90 count |
| Package Information | Strip |
- Manufactured by: charak pharma private limited
- As per physician’s advice may help in treatment of eczema
- Dosage: one tablet twice day
Additional information
| Brand |
|---|
Be the first to review “Charak Pharma Takzema Tablet – 30 Tablets”
Q & A
Ask a question
Your question will be answered by a store representative or other customers.
Thank you for the question!
Your question has been received and will be answered soon. Please do not submit the same question again.
Error
An error occurred when saving your question. Please report it to the website administrator. Additional information:
Add an answer
Thank you for the answer!
Your answer has been received and will be published soon. Please do not submit the same answer again.
Error
An error occurred when saving your answer. Please report it to the website administrator. Additional information:
Reviews
0.0 Average Rating Rated ( 0 Review )
There are no reviews yet.